SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 56 filers reported holding SPRING BK PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $969,000 | -54.1% | 613,144 | 0.0% | 0.01% | -64.3% |
| Q3 2019 | $2,109,000 | -6.8% | 613,144 | 0.0% | 0.01% | -6.7% |
| Q2 2019 | $2,263,000 | -64.8% | 613,144 | 0.0% | 0.02% | -63.4% |
| Q1 2019 | $6,432,000 | +1.0% | 613,144 | 0.0% | 0.04% | -21.2% |
| Q4 2018 | $6,371,000 | -13.8% | 613,144 | 0.0% | 0.05% | +6.1% |
| Q3 2018 | $7,388,000 | +67.1% | 613,144 | +64.3% | 0.05% | +48.5% |
| Q2 2018 | $4,422,000 | -22.9% | 373,144 | 0.0% | 0.03% | -32.7% |
| Q1 2018 | $5,739,000 | +14.4% | 373,144 | 0.0% | 0.05% | +14.0% |
| Q4 2017 | $5,015,000 | -20.2% | 373,144 | 0.0% | 0.04% | -15.7% |
| Q3 2017 | $6,284,000 | +24.4% | 373,144 | 0.0% | 0.05% | +15.9% |
| Q2 2017 | $5,052,000 | +158.8% | 373,144 | +70.2% | 0.04% | +175.0% |
| Q1 2017 | $1,952,000 | +11.4% | 219,298 | 0.0% | 0.02% | -5.9% |
| Q4 2016 | $1,752,000 | – | 219,298 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 615,384 | $8,332,000 | 1.29% |
| RTW INVESTMENTS, LP | 250,000 | $3,385,000 | 0.71% |
| Monashee Investment Management LLC | 100,000 | $1,354,000 | 0.57% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 275,728 | $3,733,000 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 175,000 | $2,370,000 | 0.40% |
| TIEDEMANN ADVISORS, LLC | 362,049 | $4,902,000 | 0.36% |
| Morse Asset Management, Inc | 63,700 | $862,000 | 0.28% |
| Private Capital Advisors, Inc. | 56,250 | $762,000 | 0.25% |
| Crestline Management, LP | 98,581 | $1,335,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 112,500 | $1,523,000 | 0.17% |